Doxazosin for reboxetine-induced urinary hesitancy

Vaccine Hesitancy

A Vaccine hesitancy reflects concerns about the decision to vaccinate oneself or one’s children. There is a broad range of factors contributing to vaccine hesitancy, including the compulsory nature of vaccines, their coincidental temporal relationships to adverse health outcomes, unfamiliarity with vaccine-preventable diseases, and lack of trust in corporations and public health agencies. Altho...

Roots of vaccine hesitancy.

Strategies for Addressing and Overcoming Vaccine Hesitancy.

Every day across the United States, family physicians wrestle with how to best communicate to patients the clear benefits and potential harms of recommended vaccinations. When the current childhood immunization schedule is followed, it is estimated that 42,000 deaths and 20 million cases of disease are prevented annually.1 Additionally, from 2001 to 2010, vaccine use derived net savings of near...

Countering Vaccine Hesitancy.

Immunizations have led to a significant decrease in rates of vaccine-preventable diseases and have made a significant impact on the health of children. However, some parents express concerns about vaccine safety and the necessity of vaccines. The concerns of parents range from hesitancy about some immunizations to refusal of all vaccines. This clinical report provides information about addressi...

Doxazosin GITS versus standard doxazosin in mild to moderate hypertension.

BACKGROUND The selective alpha 1-adrenoceptor antagonist doxazosin in both standard formulation and gastrointestinal therapeutic system (GITS) controlled-release formulation is effective for hypertension without having a negative impact on serum lipids. This study was designed to compare the relative efficacy of these two formulations of doxazosin on clinic and ambulatory blood pressure and ser...